Apimeds Pharmaceuticals US, Inc. (AMEX: APUS) last traded at $5.02, down 8.89% on the session. The quote above updates while this page is open; the figures below are drawn from Apimeds Pharmaceuticals US, Inc.’s own filings and are restated only when a new one is published.
Apimeds Pharmaceuticals US, Inc. trades on AMEX under the ticker APUS. Its market capitalisation is $7.58 million.
Valuation measures for Apimeds Pharmaceuticals US, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $7.58M |
|---|---|
| Enterprise value | $28.47M |
| Price / book | 0.07 |
| Beta | 1.49 |
Trailing-twelve-month figures tagged in Apimeds Pharmaceuticals US, Inc.'s XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$58.17M |
| Return on equity | -54.65% |
|---|
| Cash | $278.4K |
|---|
Range and volume for APUS over the past 52 weeks.
| 52-week high | $59.70 |
|---|---|
| 52-week low | $1.51 |
| Volume | 452.8K |
| Average volume | 3.62M |
| Previous close | $5.51 |
Invest a chosen dollar amount in Apimeds Pharmaceuticals US, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell APUS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.